Markets:

Overview

News

Currencies

International

Treasuries

Schrodinger, Inc. - Common Stock (NQ:SDGR)

11.61 -0.20 (-1.69%)

Streaming Delayed Price Updated: 2:47 PM EST, Feb 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Schrodinger, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Critical Insights From Schrodinger Analyst Ratings: What You Need To Know ↗

March 01, 2024

Via Benzinga

The Hot List: 3 AI Stocks Worth Buying on Weakness ↗

March 01, 2024

Firms using AI directly can be great picks for long-term investors, such as these three AI stocks to buy on weakness.

Via InvestorPlace

Topics Artificial Intelligence

Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

February 29, 2024

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results.

Via Benzinga

Key Takeaways From Schrodinger Analyst Ratings ↗

January 26, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

February 29, 2024

Via Benzinga

Why Okta Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket ↗

February 29, 2024

Shares of Okta, Inc. (NASDAQ: OKTA) shares rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and

Via Benzinga

Shoals Technologies Posts Weak Q4 Results, Joins Butterfly Network, Schrödinger And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

February 29, 2024

U.S. stock futures were lower this morning, with the Dow futures trading lower by over 100 points on Thursday.

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

February 28, 2024

Via Benzinga

Schrödinger Reports Strong Fourth Quarter and Full-Year 2023 Financial Results

February 28, 2024

From Schrödinger

Via Business Wire

Schrödinger to Participate in Upcoming Investor Conferences

February 20, 2024

From Schrödinger

Via Business Wire

Double Your Money: 3 Growth Stocks to Grab in 2024 ↗

February 19, 2024

The Russell 2000 has risen recently as interest rates have climbed, showing that the Street is now more likely to embrace growth stocks.

Via InvestorPlace

Earnings Scheduled For February 28, 2024 ↗

February 28, 2024

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenue of $1.69 billion.

Via Benzinga

AI-Powered Drug Discovery Stocks Index Up 18% Last Week, Led By BioXcel Therapeutics ↗

February 19, 2024

The AI-powered drug discovery market is projected to grow at a 30% CAGR between now and 2030, with annual sales in excess of $50 billion anticipated. An AI drug discovery revolution is underway.

Via Talk Markets

Topics Artificial Intelligence

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

February 16, 2024

From Schrödinger

Via Business Wire

Schrödinger to Announce Fourth Quarter and Full-Year 2023 Financial Results on February 28

February 14, 2024

From Schrödinger

Via Business Wire

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

January 19, 2024

From Schrödinger

Via Business Wire

Schrödinger Provides Update on Progress Across the Business and Outlines 2024 Development and Operational Goals

January 08, 2024

From Schrödinger

Via Business Wire

AI-Focused Drug Discovery Stocks Index Up 26% In December ↗

December 29, 2023

With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds massive potential to increase the accessibility of drugs and to treat presently incurable conditions.

Via Talk Markets

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

December 19, 2023

From Schrödinger

Via Business Wire

These Are the 3 Hottest Biopharma Trends of 2024. Should You Invest? ↗

December 18, 2023

2024 is going to be a sizzler in the biopharma sector.

Via The Motley Fool

AI-Focused Drug Discovery Stocks Index Up 10.6% Last Week ↗

December 17, 2023

A new study concludes that the AI method of drug discovery is up to 250 times more efficient than the traditional method.

Via Talk Markets

Topics Artificial Intelligence

Schrödinger Highlights Progress of Clinical Programs and Discloses Three New Programs at First Therapeutics Pipeline Investor Event

December 14, 2023

From Schrödinger

Via Business Wire

Artificial Intelligence in Healthcare: 3 Stocks Transforming the Industry ↗

December 11, 2023

Companies are applying AI in healthcare, leading to better outcomes and stronger performance for their stocks.

Via InvestorPlace

Topics Artificial Intelligence

The 10 Stocks Using AI To Develop New Drugs Were Up 4%, On Average, Last Week ↗

December 11, 2023

If, as Morgan Stanley postulates, a $50 billion AI drug discovery revolution is underway, here are 10 publicly-traded micro- and small-cap clinical stage pharma companies that are embracing AI to...

Via Talk Markets

Topics Artificial Intelligence

Schrödinger Presents Data Supporting Advancement of SGR-1505 and SGR-2921 at American Society of Hematology 2023 Annual Meeting

December 10, 2023

From Schrödinger

Via Business Wire

Micro/Small Cap Companies Using AI In Drug Discovery Up 35% In November ↗

December 06, 2023

The AI method is up to 250 times more efficient than the traditional method of drug discovery. reducing timelines for drug discovery, increasing accuracy of efficacy and safety predictions.

Via Talk Markets

Topics Artificial Intelligence

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

November 17, 2023

From Schrödinger

Via Business Wire

3 Cutting-Edge Biotech Stocks for the Bold Investor ↗

November 14, 2023

With broader market concerns rising, investors may want to consider the relatively insulated allure of biotech stocks to buy.

Via InvestorPlace

AI Alert: 3 Healthcare Stocks That Are Investing in Artificial Intelligence ↗

November 09, 2023

We’re still in the initial stages of a massively disruptive artificial intelligence (AI) boom that's greatly impacting healthcare.

Via InvestorPlace

Topics Artificial Intelligence

Schrödinger to Participate in Upcoming Investor Conferences

November 06, 2023

From Schrödinger

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Schrodinger, Inc. - Common Stock (NQ:SDGR)

All News about Schrodinger, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today